Retension Pharmaceuticals Inc. RTSN · News

website

Retension Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing ...

Price12.39

Market Cap103.23 M

Float2.89 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

FEATURED

Retension Pharmaceuticals to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

FALLS CHURCH, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) ("Retension" or the "Company"), a clinical-stage biopharmaceutical company focused on developing

Summary

Nov 5, 2026, 8:02 AM ·Globe Newswire

RECENT

Retension Pharmaceuticals Announces Pricing of Initial Public Offering

FALLS CHURCH, Va., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retension Pharmaceuticals, Inc. (NASDAQ:RTSN) ("Retension" or the "Company"), a clinical-stage biopharmaceutical company focused on developing

Oct 8, 2026, 9:35 PM ·Globe Newswire